|Articles|October 8, 2021
Daily OTC Pearl: Vitamin B2
Author(s)Saro Arakelians, PharmD
Causes of vitamin B2 deficiency may include alcoholism, burns, cancer, diarrhea, fever, illness, infection, and liver disease.
Advertisement
OTC/Lifestyle Pearl of the Day: Vitamin B2
Indication: Riboflavin (vitamin B2) is needed to help break down carbohydrates, proteins, and fats. It also makes it possible for oxygen to be used by your body.
Insight:
- Vitamin B2 is a water-soluble vitamin that is flushed out of the body daily, so it must be restored each day.
- The best way to obtain this vitamin is by eating foods that are rich in riboflavin.
- Foods with vitamin B2: Riboflavin is found in eggs, nuts, dairy products, meats, broccoli, brewer's yeast, brussels sprouts, wheat germ, wild rice, mushrooms, soybeans, green leafy vegetables, and whole grain and enriched cereals and bread.
- Causes of vitamin B2 deficiency may include alcoholism, burns, cancer, diarrhea, fever, illness, infection, and liver disease.
- Recommended daily allowance for Riboflavin is as below:
- Adults and teenage males—1.4 to 1.8 mg per day.
- Adults and teenage females—1.2 to 1.3 mg per day.
- Pregnant females—1.6 mg per day.
- Breast-feeding females—1.7 to 1.8 mg per day.
- Children 7 to 10 years of age—1.2 mg per day.
- Children 4 to 6 years of age—1.1 mg per day.
- Children birth to 3 years of age—0.4 to 0.8 mg per day
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
4
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
5